About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 95 record(s)
Req # A-2023-00068
a document produced by the CNSC in 2022 entitled "CNSC Management Briefing Note On CANDU Primary Cooling System Over-Pressure Protection System Design Review Findings". Please include every draft and revised version of this document.Organization: Canadian Nuclear Safety Commission
January 2024
Req # A-2023-00074
All correspondence from January 1, 2023 current to November 6, 2023 from the CNSC to the Impact Assessment Agency of Canada (IAAC) and/or Environment Climate Change Canada, as well as internal briefing notes communications and memos regarding: 1) the five-year review of the Project List / Physical Activities Regulation of the Impact Assessment Act 2) thresholds and project triggers for inclusion of projects on the Project List 3) any mention of small modular reactors in relation to the Project ListOrganization: Canadian Nuclear Safety Commission
January 2024
Req # A-2020-000850
Adverse Drug Reactions (ADRs). Report numbers: E2B_03195128, E2B_03196066, E2B_03198278, E2B_03198292.Organization: Health Canada
January 2024
Req # A-2021-000440
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-100203-189, Status of the use of Remotely Piloted Aircraft Systems (drones) for pesticide application in Canada.Organization: Health Canada
January 2024
Req # A-2021-001787
Adverse Drug Reaction (ADR) for AGALSIDASE BETA. Report number: E2B_04595165.Organization: Health Canada
January 2024
Req # A-2022-000123
Adverse Drug Reaction (ADR) for ALFUZOSIN HYDROCHLORIDE. Report number: E2B_05007203.Organization: Health Canada
January 2024
Req # A-2023-000126
Adverse Drug Reactions (ADRs). Report numbers: E2B_00675714, E2B_02977829, E2B_03128456.Organization: Health Canada
January 2024
Req # A-2023-001017
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-107682-242, Deputy Ministerial Meeting with Helium Developers Association of Canada.Organization: Health Canada
January 2024
Req # A-2023-001167
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-109485-722, Deputy Ministerial Meeting with the President and Chief Executive Officer of The Ottawa Hospital.Organization: Health Canada
January 2024
Req # A-2023-000483
A list of every drug approved under Health Canada's Special Access Program (SAP) between January 1, 2018 and July 6, 2023.Organization: Health Canada
January 2024